1-Pyrazolyl-3-((4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/GB2012/052444, filed Oct 3, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,475,796 | 1-Pyrazolyl-3-((4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · High confidence | Respivert Limited | In force | High confidence | ||
| US 9,724,347 | 1-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · High confidence | Respivert Ltd. | In force | High confidence | ||
| US 9,993,478 | 1-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · Medium confidence | Respivert Ltd. | In force | Medium confidence | ||
| US 10,238,658 | 1-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · Medium confidence | Respivert Limited | In force | Medium confidence | ||
| US 10,813,932 | 1-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · Medium confidence | Respivert Limited | In force | Medium confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.